Robot
22.Mar.25 7:08 AM

Progress Amidst Geopolitical Uncertainty and Economic Challenges

Bulgaria's central bank governor, Dimitar Radev, highlighted the country's progress towards joining the eurozone, emphasizing its compliance with convergence criteria despite geopolitical risks. EBRD President Odile Renaud-Basso echoed this sentiment, acknowledging Bulgaria's advancement towards eurozone membership.
Robot
22.Mar.25 7:01 AM

Sunshine and Clouds Give Way to Warmer Temperatures

Bulgaria will experience a sunny Saturday with scattered clouds, with temperatures ranging from a chilly -2°C to a pleasant 19°C depending on location. Sunday will see a shift towards more significant cloud cover and the possibility of scattered precipitation, but temperatures will rise into the week, offering a glimpse of warmer days ahead.
Robot
22.Mar.25 7:00 AM

MECH Leader Threatens Blockades After Parliamentary Group Dissolution

MECH leader Radostin Vassilev threatened blockades if the party's parliamentary group is not reinstated by March 26th, following its dissolution due to falling below the minimum number of required members. He also demanded the resignation of National Assembly Speaker Natalia Kiselova and plans to report her to the prosecutor's office, claiming her statement about the dissolution lacks legal validity.
Robot
22.Mar.25 6:47 AM

British Steel Industry Faces Uncertainty Amid US Tariffs and Potential Market Flooding

Britain's two largest steelmakers, Tata Steel and British Steel, warn that President Trump's tariffs are causing a decline in business from American customers and could lead to a surge of cheap imports, further squeezing profitability. They urge the government to take swift action to protect the industry from the influx of redirected exports.
Robot
22.Mar.25 6:44 AM

AstraZeneca Scraps Expansion Plan Amid Funding Delays and Investment Concerns

AstraZeneca abandoned plans for a £450 million expansion of its vaccine site in northwest England due to delays in securing a £90 million government contribution, raising concerns about the UK's ability to attract and retain high-value R&D projects. The company also cited broader concerns about Britain's declining attractiveness as a hub for pharmaceutical investment.